9-2039776-ACAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-ACAGCAGCAGCAG

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP3BP6BS1BS2

The NM_003070.5(SMARCA2):​c.690_707delGCAGCAGCAGCAGCAGCA​(p.Gln231_Gln236del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000153 in 1,596,344 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00031 ( 0 hom., cov: 26)
Exomes 𝑓: 0.00014 ( 0 hom. )

Consequence

SMARCA2
NM_003070.5 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 1.94

Publications

9 publications found
Variant links:
Genes affected
SMARCA2 (HGNC:11098): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is highly similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. Alternatively spliced transcript variants encoding different isoforms have been found for this gene, which contains a trinucleotide repeat (CAG) length polymorphism. [provided by RefSeq, Jan 2014]
SMARCA2 Gene-Disease associations (from GenCC):
  • intellectual disability-sparse hair-brachydactyly syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_003070.5
BP6
Variant 9-2039776-ACAGCAGCAGCAGCAGCAG-A is Benign according to our data. Variant chr9-2039776-ACAGCAGCAGCAGCAGCAG-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 1366910.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000312 (47/150532) while in subpopulation AFR AF = 0.00066 (27/40908). AF 95% confidence interval is 0.000466. There are 0 homozygotes in GnomAd4. There are 28 alleles in the male GnomAd4 subpopulation. Median coverage is 26. This position passed quality control check.
BS2
High AC in GnomAd4 at 47 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCA2NM_003070.5 linkc.690_707delGCAGCAGCAGCAGCAGCA p.Gln231_Gln236del disruptive_inframe_deletion Exon 4 of 34 ENST00000349721.8 NP_003061.3
SMARCA2NM_001289396.2 linkc.690_707delGCAGCAGCAGCAGCAGCA p.Gln231_Gln236del disruptive_inframe_deletion Exon 4 of 34 NP_001276325.1
SMARCA2NM_139045.4 linkc.690_707delGCAGCAGCAGCAGCAGCA p.Gln231_Gln236del disruptive_inframe_deletion Exon 4 of 33 NP_620614.2
SMARCA2NM_001289397.2 linkc.690_707delGCAGCAGCAGCAGCAGCA p.Gln231_Gln236del disruptive_inframe_deletion Exon 4 of 33 NP_001276326.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCA2ENST00000349721.8 linkc.690_707delGCAGCAGCAGCAGCAGCA p.Gln231_Gln236del disruptive_inframe_deletion Exon 4 of 34 5 NM_003070.5 ENSP00000265773.5

Frequencies

GnomAD3 genomes
AF:
0.000312
AC:
47
AN:
150432
Hom.:
0
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.000662
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000397
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000196
Gnomad SAS
AF:
0.000423
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000133
Gnomad OTH
AF:
0.000967
GnomAD4 exome
AF:
0.000136
AC:
197
AN:
1445812
Hom.:
0
AF XY:
0.000132
AC XY:
95
AN XY:
718568
show subpopulations
African (AFR)
AF:
0.000458
AC:
15
AN:
32786
American (AMR)
AF:
0.000117
AC:
5
AN:
42718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25866
East Asian (EAS)
AF:
0.000858
AC:
33
AN:
38448
South Asian (SAS)
AF:
0.000177
AC:
15
AN:
84908
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51680
Middle Eastern (MID)
AF:
0.000180
AC:
1
AN:
5568
European-Non Finnish (NFE)
AF:
0.000110
AC:
121
AN:
1104132
Other (OTH)
AF:
0.000117
AC:
7
AN:
59706
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000312
AC:
47
AN:
150532
Hom.:
0
Cov.:
26
AF XY:
0.000381
AC XY:
28
AN XY:
73486
show subpopulations
African (AFR)
AF:
0.000660
AC:
27
AN:
40908
American (AMR)
AF:
0.000397
AC:
6
AN:
15128
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3462
East Asian (EAS)
AF:
0.000197
AC:
1
AN:
5082
South Asian (SAS)
AF:
0.000424
AC:
2
AN:
4712
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10366
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000133
AC:
9
AN:
67586
Other (OTH)
AF:
0.000957
AC:
2
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
12

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Aug 17, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with SMARCA2-related conditions. This variant is not present in population databases (gnomAD no frequency). This variant, c.690_707del, results in the deletion of 6 amino acid(s) of the SMARCA2 protein (p.Gln233_Gln238del), but otherwise preserves the integrity of the reading frame.

Oct 03, 2023
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SMARCA2: BS1

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.9
Mutation Taster
=179/21
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113070757; hg19: chr9-2039776; API